Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate

dc.contributor.authorPhuphuakrat A.
dc.contributor.authorPasomsub E.
dc.contributor.authorChantratita W.
dc.contributor.authorMahasirimongkol S.
dc.contributor.authorDisthabanchong S.
dc.contributor.authorSungkanuparph S.
dc.contributor.authorKiertiburanakul S.
dc.contributor.otherMahidol University
dc.date.accessioned2023-06-18T17:24:51Z
dc.date.available2023-06-18T17:24:51Z
dc.date.issued2022-01-01
dc.description.abstractTenofovir disoproxil fumarate (TDF) associates with renal tubular dysfunction (RTD) in some people living with HIV (PLWH). We studied clinical and genetic factors associated with RTD in Thai PLWH receiving TDF. RTD was diagnosed in 13 of 65 (20%) patients. The median (interquartile range) age and CD4 cell counts were 43.8 (40.4-50.9) years and 554 (437-716) cells/mm3, respectively. The median duration of TDF use was 46.9 (31.5-54.1) months. Univariate logistic regression demonstrated body mass index (BMI), concomitant use of protease inhibitor (PI), hyperlipidemia, and homozygous C/C SNP rs1059751 of ABCC4 gene as predisposing factors of RTD. In multivariate model, concomitant use of PI [adjusted odds ratio (aOR) 11.39; 95% confidence interval (CI), 1.59- 81.56; P = 0.015], hyperlipidemia (aOR 8.59; 95% CI, 1.46-50.40; P = 0.017), and BMI (aOR 0.76; 95% CI, 0.59-0.98; P = 0.037) remained associated with RTD in patients receiving TDF. PLWH receiving TDF with the presence of these factors should be closely monitored for RTD.
dc.identifier.citationJournal of the International Association of Providers of AIDS Care Vol.21 (2022)
dc.identifier.doi10.1177/23259582221134751
dc.identifier.eissn23259582
dc.identifier.issn23259574
dc.identifier.pmid36314476
dc.identifier.scopus2-s2.0-85141004846
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/85042
dc.rights.holderSCOPUS
dc.subjectImmunology and Microbiology
dc.titleRisk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85141004846&origin=inward
oaire.citation.titleJournal of the International Association of Providers of AIDS Care
oaire.citation.volume21
oairecerif.author.affiliationFaculty of Medicine Ramathibodi Hospital, Mahidol University
oairecerif.author.affiliationThailand Ministry of Public Health

Files

Collections